H1B Salary Data

Home › Employers › Avalere Health US, Inc

Avalere Health US, Inc: H-1B salaries and sponsorship

Avalere Health US, Inc filed 4 labor condition applications for H-1B and related visas in fiscal years 2023–2026; certified: 3. Median offered salary: $170,568.

Applications (LCAs)4
Certified3
Employer addressWashington, DC
H-1B dependent employerNo
Median offered salary$170,568
Middle half of salaries$133,716–$175,934
10th–90th percentile$111,606–$179,153

Does Avalere Health US, Inc sponsor H-1B visas?

Avalere Health US, Inc filed 4 labor condition applications in fiscal years 2023–2026, the latest submitted on Sep 18, 2025. An LCA is the first step of an H-1B petition, so the employer has sponsored or prepared to sponsor H-1B workers; it does not guarantee sponsorship for any particular job. Check the employer's own job listings.

Salaries by job title

Job titleLCAsMedian salary
Senior Research Scientist2$170,568
Director, Strategy1$181,299
Consultant I1$96,865

Applications by fiscal year

Fiscal yearLCAsMedian salary
FY20254$170,568

Prevailing wage levels

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Where the jobs are

Occupations

Latest applications

Job titleBase salaryLocationSubmittedStart dateStatus
Consultant I$96,865
Level II
Jersey City, NJSep 18, 2025Sep 18, 2025Certified
Director, Strategy$181,299
Level IV
New York, NYMay 28, 2025Oct 1, 2025Certified
Senior Research Scientist$170,568
Level IV
Charlotte, NCMay 22, 2025Jul 1, 2025Certified
Senior Research Scientist$170,568
Level IV
Charlotte, NCMay 22, 2025Aug 1, 2025Withdrawn

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).